Physician profile
Muzammil Memon
NPI 1629738158
$25,074.37
in general payments reported to CMS, 2019-2025
12 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14K · 2023: $8,860 · 2024: $1,228 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,212 · Education: $3,315 · Food and Beverage: $2,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,212.22 |
| Education | $3,315.00 |
| Food and Beverage | $2,601.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,429.00 | 2022-2023 | Knee & Hip Instruments |
| Smith+Nephew, INC. | $7,089.98 | 2022-2024 | Q-Fix, Ultrabutton, Accu-Pass |
| Stryker Corporation | $5,614.61 | 2023-2025 | Mako, Insignia, Restoration |
| Rattan and Associates | $1,124.04 | 2023 | |
| Depuy Synthes Sales INC. | $253.76 | 2022-2024 | Dynacord, Healix Knotless Peek, Monovisc |
| Zimmer Biomet Holdings, INC. | $171.65 | 2022-2023 | Persona |
| Stratus Medical, LLC | $139.70 | 2025 | Nimbus |
| Embody, INC. | $133.74 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $44.42 | 2024-2025 | Exparel, Zilretta, Iovera |
| Medical Device Business Services, INC. | $29.15 | 2023 | Attune |
| Baxter Healthcare | $24.73 | 2025 | Perclot |
| Kci USA, INC. | $19.59 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muzammil Memon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.